Dr. Benjamin Lok, MD
Claim this profilePrincess Margaret Cancer Center, University Health Network
Affiliated Hospitals
Princess Margaret Cancer Center, University Health Network
Clinical Trials Benjamin Lok, MD is currently running
Radiotherapy
for Arrhythmias
This is a prospective, single-center, phase II trial that will be monitoring the safety and efficacy of using stereotactic ablative radiotherapy (SBRT) to treat patients with a medical condition affecting heart rate and rhythm (refractory arrhythmias) within the University Health Network (Princess Margaret Cancer Centre and Toronto General Hospital). The primary objective will be to prospectively monitor patient cardiac outcomes following SBRT.
Recruiting
1 award
N/A
2 criteria
Talazoparib + Radiotherapy
for Small Cell Lung Cancer
This is a phase I, dose escalating study evaluating the safety of combining talazoparib and low dose consolidative thoracic radiotherapy for small cell lung cancer patients. This study will also determine the maximum tolerated dose (MTD) of talazoparib in combination with low dose thoracic radiotherapy. Patients will start on talazoparib on day 1 of study intervention, and will continue to orally take talazoparib until the last day of radiation therapy. Up to 24 patients will be enrolled to the study, where the first 3 patients will start with a starting dose level of talazoparib is 0.5 mg PO once daily. This will increase to 1mg daily with each new cohort.
Recruiting
1 award
Phase 1
7 criteria
More about Benjamin Lok, MD
Clinical Trial Related
4 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Benjamin Lok, MD has experience with
- Low Dose Radiotherapy (RT)
- Talazoparib
- Stereotactic Ablative Radiotherapy
Breakdown of trials Benjamin Lok, MD has run
Small Cell Lung Cancer
Arrhythmia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Benjamin Lok, MD specialize in?
Benjamin Lok, MD focuses on Lung Cancer and Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Benjamin Lok, MD currently recruiting for clinical trials?
Yes, Benjamin Lok, MD is currently recruiting for 2 clinical trials in Toronto Ontario. If you're interested in participating, you should apply.
Are there any treatments that Benjamin Lok, MD has studied deeply?
Yes, Benjamin Lok, MD has studied treatments such as Low Dose Radiotherapy (RT), Talazoparib, Stereotactic Ablative Radiotherapy.
What is the best way to schedule an appointment with Benjamin Lok, MD?
Apply for one of the trials that Benjamin Lok, MD is conducting.
What is the office address of Benjamin Lok, MD?
The office of Benjamin Lok, MD is located at: Princess Margaret Cancer Center, University Health Network, Toronto, Ontario M5G 2M9 Canada. This is the address for their practice at the Princess Margaret Cancer Center, University Health Network.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.